Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Irinotecan and gemcitabine in inoperable biliary tract cancer
NCT00832689Phase 2Completed
- Sponsor
- Yonsei University
- Start
- Jun 2008
- Primary completion
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of irinotecan, gemcitabine in biliary tract cancer (BTC), sponsored by Yonsei University. Started Jun 2008; status: completed.
02
Drugs
irinotecangemcitabine
03
Conditions
biliary tract cancer (BTC)
Beyond the preview
Go deeper on NCT00832689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00832689.